NEK5, one of the least studied of the family, has recently gained attention due to its potential involvement in breast and prostate cancer [17–19], although the signalling mechanisms and pathways utilized by NEK5 in these contexts remained poorly characterized. Here, NEK5 is linked to prostate carcinoma.